Report overview
Psoriasis is an autoimmune skin disease that causes scaling, skin redness and irritation. Psoriasis causes red, scaly patches that are generally found on the elbows, fingernails, scalp, palms, knees, face, feet and inside the mouth. Factors that can trigger psoriasis include infections, heavy alcohol consumption, cold weather, certain medications, smoking, stress and injury to the skin such as bug bite, cut and sever sunburn. The signs and symptoms of psoriasis vary from person to person which includes dry, cracked skin that may bleed, red patches of skin covered with silvery scales, small scaling spots, itching, burning, swollen and stiff joints. Psoriasis may be classified into various types such as plaque psoriasis, scalp psoriasis, pustular psoriasis, psoriatic arthritis, guttate psoriasis, nail psoriasis, erythrodermic psoriasis and inverse psoriasis. Various treatments for psoriasis are oral medication, topical medication and biologics injections. Psoriasis can also be treating by phototherapy treatment which includes ultraviolet light therapy, laser treatment, tanning beds, psoralen +UVA and sunlight treatment. Psoriasis can occur in any part of the body and it is associated with other health conditions such as heart disease, diabetes and depression.
This report aims to provide a comprehensive presentation of the global market for Systemic Psoriasis Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Systemic Psoriasis Therapeutics. This report contains market size and forecasts of Systemic Psoriasis Therapeutics in global, including the following market information:
Global Systemic Psoriasis Therapeutics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Systemic Psoriasis Therapeutics market was valued at US$ 12060 million in 2022 and is projected to reach US$ 19640 million by 2029, at a CAGR of 7.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
One trend resulting in the strong growth of this market is the advent of biologics with novel MOA and cell-based strategies. This market is expected to witness the launch of biologic agents that target the disease pathway specifically, including IL-17/IL-17R receptor inhibitors. Drugs such as brodalumab, guselkumab, and tildrakizumab are undergoing Phase III clinical trials.
We surveyed the Systemic Psoriasis Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Systemic Psoriasis Therapeutics Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Systemic Psoriasis Therapeutics Market Segment Percentages, by Type, 2022 (%)
Biologics
Small Molecules
Global Systemic Psoriasis Therapeutics Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Systemic Psoriasis Therapeutics Market Segment Percentages, by Application, 2022 (%)
Mild Psoriasis
Moderate Psoriasis
Severe Psoriasis
Global Systemic Psoriasis Therapeutics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Systemic Psoriasis Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Systemic Psoriasis Therapeutics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Systemic Psoriasis Therapeutics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie
Johnson & Johnson
Celgene
Amgen
Pfizer
Outline of Major Chapters:
Chapter 1: Introduces the definition of Systemic Psoriasis Therapeutics, market overview.
Chapter 2: Global Systemic Psoriasis Therapeutics market size in revenue.
Chapter 3: Detailed analysis of Systemic Psoriasis Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Systemic Psoriasis Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
